Skip to main content
Clinical Trials/NCT00819286
NCT00819286CompletedNot Applicable

A Prospective, Randomized-Controlled, Multicenter Study Evaluating Primary Plating in High-Risk Median Sternotomy Patients for Osteosynthesis and Pain

Zimmer Biomet6 sites in 2 countries140 target enrollmentStarted: November 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
140
Locations
6
Primary Endpoint
Activity Based Total Visual Analog Pain Score

Study Overview

Brief Summary

The goal of this study is to evaluate sternal osteosynthesis, chest wall pain and return to normal activity in open heart surgery patients who had their breast bone closed either with wires or plates.

Detailed Description

Median sternotomy patients will be randomized to either wire or rigid fixation groups. A scheduled evaluation period will record clinical parameters. Enrollment has ended with one hundred forty (140) patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Masking Description

Participant blinded to treatment assignment until completion of study.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients undergoing median sternotomy;
  • •Patients eighteen (18) years of age or older;
  • •Patients presenting two or more risk factors such as diabetes mellitus, Chronic Obstructive Pulmonary Disease, obesity (BMI > 30), osteoporosis, Renal failure, Chronic steroid use, Immunosuppression, Redo sternotomy, Neurologic dysfunction severely affecting ambulation,
  • •Off mid-line sternotomy
  • •bilateral IMA use
  • •Long cardio-pulmonary bypass runs
  • •Transverse fractures of the sternum

Exclusion Criteria

  • •Patients with a non-standard sternotomy;
  • •Patients with an off-midline sternotomy that reduced the bony margin to <2mm
  • •Patients under eighteen (18) years of age;
  • •Patients that are pregnant or currently lactating;
  • •Patients presenting intra-operative conditions that would require the use of rigid fixation and/or additional post-sternotomy mechanical support beyond wire cerclage due to surgical evaluation,
  • •Patients defined within the New York Heart Association (NYHA) or Canadian Cardiovascular Society (CCS) functional Class IV for congestive heart failure,
  • •Patients presenting emergent/salvage cardiac acuity as defined per the Society of Thoracic Surgeons (STS) guidelines: i.e., patients undergoing cardiopulmonary resuscitation en route to the operating room or prior to induction of anesthesia;
  • •Patients undergoing post-operative revision procedures that treat the original sternotomy in such a way as to affect outcome (antibiotic irrigation, debridement or other treatment to the osteotomy);
  • •Patients unwilling or unable to return for follow-up;
  • •Lacking the ability to follow instructions;
  • •Intraoperative death.

Arms & Interventions

wire (control)

Active Comparator

patients will have their sternum closed using wire (stainless steel surgical wire).

Intervention: wire (control) (Device)

SternaLock Rigid Fixation Plates

Experimental

patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates.

Intervention: SternaLock Rigid Fixation Plates (Device)

Outcomes

Primary Outcomes

Activity Based Total Visual Analog Pain Score

Time Frame: 6 months

Postoperative VAS pain scores (scale of 0-10 for each; 0= no pain, 10= worst pain imaginable) were evaluated as a function of resting, coughing, sneezing and general movement. The sum of these was used to derive an "Activity Based Total Visual Analog Pain Score", (scale of 0-40; 0= no pain, 40= worst pain imaginable). For this primary endpoint analysis, the total score at 6 months was evaluated.

CT Scan Evaluation of Sternal Bone Healing

Time Frame: 3 and 6 Months

Quantitative evaluation of sternal bone healing at 5 anatomical locations along the sternum using a 6 point quantitative scale (0= no healing and 5= complete healing)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (6)

Loading locations...

Similar Trials